Jul 31, 2013

World's first iPS clinical research for retina regeneration begins

The world’s first clinical research using induced pluripotent stem cells, known as iPS cells, for the regeneration of retina begins Thursday, according to a Japanese team of researchers. The state-backed scientific research institute Riken, based in Wako, Saitama Prefecture, and the Foundation for Biomedical ...

Jul 20, 2013

World's first clinical trials with human iPS cells OK'd

The government has signed off on the world’s first clinical trials to use induced pluripotent stem (iPS) cells harvested from the bodies of human patients. Health minister Norihisa Tamura on Friday gave his seal of approval to a proposal by two research institutes that ...

Mar 1, 2013

Riken to apply for approval to conduct iPS clinical research

The government-backed Riken scientific research institute said Thursday it has applied for government permission to conduct clinical research using induced pluripotent stem cells, known as iPS cells, to regenerate retinas. If the ministry accepts Riken’s plan, it would be the world’s first clinical research ...

Jan 30, 2013

Stockpile of artificial stem cells in works

Kyoto University professor Shinya Yamanaka has revealed that a project to stockpile artificially derived stem cells for clinical research will start in early February. The project is intended to create induced pluripotent stem cells from the blood of people with rare cell forms, known ...

Jan 23, 2013

Kyoto team generates kidney tissue from iPS cells

A research team at Kyoto University has succeeded in generating kidney tissue from induced pluripotent stem cells, or iPS cells, for the first time ever. The accomplishment by the team led by Kenji Osafune, an associate professor at the university’s Center for iPS Cell ...